|
KMID : 0369820110410060347
|
|
Jorunal of Korean Pharmaceutical Sciences
2011 Volume.41 No. 6 p.347 ~ p.354
|
|
|
Controlled Transdermal Delivery of Loxoprofen from an Ethylene-Vinyl Acetate Matrix
|
|
Ryu Sang-Rok
Shin Sang-Chul
|
|
|
Abstract
|
|
|
|
Repeated oral administration of loxoprofen can induce many side effects such as gastric disturbances and acidosis. Therefore, we considered alternative routes of administration for loxoprofen to avoid such adverse effects. The aim of this study was to develop an ethylene-vinyl acetate (EVA) matrix system containing a permeation enhancer for enhanced transdermal delivery of loxoprofen. The EVA matrix containing loxoprofen was fabricated and the effects of drug concentration, temperature, enhancer and plasticizer on drug release were studied from the loxoprofen-EVA matrix. The solubility of loxoprofen was highest at 40% (v/v) PEG 400. The release rate of drug from drug-EVA matrix increased with increased loading dose and temperature. The release rate was proportional to the square root of loading dose. The activation energy (Ea), which was measured from the slope of log P versus 1000/T, was 5.67 kcal/mol for a 2.0% loaded drug dose from the EVA matrix. Among the plasticizer used, diethyl phthalate showed the highest release rate of loxoprofen. Among the enhancers used, polyoxyethylene 2-oleyl ether showed the greatest enhancing effect. In conclusion, for the enhanced controlled transdermal delivery of loxoprofen, the application of the EVA matrix containing plasticizer and penetration enhancer could be useful in the development of a controlled drug delivery system.
|
|
|
KEYWORD
|
|
|
Loxoprofen, Ethylene-vinyl acetate, Controlled transdermal delivery, Matrix, Plasticizer, Permeation enhancer
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|